tilorone has been researched along with Pneumonia, Viral in 2 studies
Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
Excerpt | Relevance | Reference |
---|---|---|
"Tilorone has been long neglected by the west in many respects but it deserves further reassessment in light of current and future needs for broad-spectrum antivirals." | 1.56 | Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond. ( Ekins, S; Lane, TR; Madrid, PB, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Jeon, S | 1 |
Ko, M | 1 |
Lee, J | 1 |
Choi, I | 1 |
Byun, SY | 1 |
Park, S | 1 |
Shum, D | 1 |
Kim, S | 1 |
Ekins, S | 1 |
Lane, TR | 1 |
Madrid, PB | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of Silver Nanoparticles as an Oropharyngeal Product (Mouthwash) and Nasal Hygiene, by Health Personnel Working at the Tijuana General Hospital Exposed to Patients Diagnosed With Atypical Pneumonia Caused by SARS-CoV-2[NCT04894409] | 231 participants (Actual) | Interventional | 2020-04-24 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for tilorone and Pneumonia, Viral
Article | Year |
---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiop | 2020 |
Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.
Topics: Animals; Antiviral Agents; Betacoronavirus; Chikungunya virus; Coronavirus Infections; COVID-19; COV | 2020 |